On the other hand, NNC0114-0005, a human recombinant anti-IL-21 monoclonal antibody for treatment of RA, was assessed in 20 RA patients treated with methotrexate in comparison with 44 healthy subjects (HS). Here, IL21 is linked to rheumatoid arthritis.